Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells.

Liu F, Gomez Garcia AM, Meyskens FL Jr.

J Invest Dermatol. 2012 Aug;132(8):2033-41. doi: 10.1038/jid.2012.119. Epub 2012 Apr 19.

2.

Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.

Chen D, Zhang Y, Zhang X, Li J, Han B, Liu S, Wang L, Ling Y, Mao S, Wang X.

Acta Histochem. 2013 Mar;115(2):128-36. doi: 10.1016/j.acthis.2012.05.004. Epub 2012 Jun 9.

PMID:
22683084
3.

Study designs to investigate Nox1 acceleration of neoplastic progression in immortalized human epithelial cells by selection of differentiation resistant cells.

Sattayakhom A, Chunglok W, Ittarat W, Chamulitrat W.

Redox Biol. 2013 Dec 21;2:140-7. doi: 10.1016/j.redox.2013.12.010. eCollection 2014. Review.

4.

Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.

Hata H, Kitamura T, Higashino F, Hida K, Yoshida K, Ohiro Y, Totsuka Y, Kitagawa Y, Shindoh M.

Oncol Rep. 2008 May;19(5):1093-8.

PMID:
18425363
5.

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E.

Mol Cancer Ther. 2005 Nov;4(11):1717-28.

6.
7.

Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.

Ha TY, Hwang S, Moon KM, Won YJ, Song GW, Kim N, Tak E, Ryoo BY, Hong HN.

Anticancer Res. 2015 Apr;35(4):1967-76.

PMID:
25862849
8.

Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Briggs JJ, Haugen MH, Johansen HT, Riker AI, Abrahamson M, Fodstad Ø, Maelandsmo GM, Solberg R.

BMC Cancer. 2010 Jan 15;10:17. doi: 10.1186/1471-2407-10-17.

9.

Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3).

Tsuji T, Kawada Y, Kai-Murozono M, Komatsu S, Han SA, Takeuchi K, Mizushima H, Miyazaki K, Irimura T.

Clin Exp Metastasis. 2002;19(2):127-34.

PMID:
11964076
10.

Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion.

Tatti O, Arjama M, Ranki A, Weiss SJ, Keski-Oja J, Lehti K.

PLoS One. 2011;6(12):e28325. doi: 10.1371/journal.pone.0028325. Epub 2011 Dec 2.

11.

Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.

Katchman BA, Antwi K, Hostetter G, Demeure MJ, Watanabe A, Decker GA, Miller LJ, Von Hoff DD, Lake DF.

Mol Cancer Res. 2011 Dec;9(12):1621-31. doi: 10.1158/1541-7786.MCR-11-0018. Epub 2011 Oct 11.

12.

TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.

Weiss MB, Abel EV, Mayberry MM, Basile KJ, Berger AC, Aplin AE.

Cancer Res. 2012 Dec 15;72(24):6382-92. doi: 10.1158/0008-5472.CAN-12-1033. Epub 2012 Dec 7.

13.

Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.

Iida J, Wilhelmson KL, Price MA, Wilson CM, Pei D, Furcht LT, McCarthy JB.

J Invest Dermatol. 2004 Jan;122(1):167-76.

14.

CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells.

Fontijn D, Duyndam MC, van Berkel MP, Yuana Y, Shapiro LH, Pinedo HM, Broxterman HJ, Boven E.

Br J Cancer. 2006 Jun 5;94(11):1627-36.

15.

Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.

Docampo MJ, Cabrera J, Rabanal RM, Bassols A.

Am J Vet Res. 2011 Aug;72(8):1087-96. doi: 10.2460/ajvr.72.8.1087.

PMID:
21801067
16.

N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.

Lee JC, Chung LC, Chen YJ, Feng TH, Juang HH.

Cancer Lett. 2014 Dec 28;355(2):242-52. doi: 10.1016/j.canlet.2014.08.035. Epub 2014 Sep 10.

PMID:
25218595
17.
18.

Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.

Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.

Oncogene. 2001 Jun 7;20(26):3363-75.

19.

Expression of Hugl-1 is strongly reduced in malignant melanoma.

Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S, Strand D, Bosserhoff AK.

Oncogene. 2006 Jan 5;25(1):103-10.

PMID:
16170365
20.

Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.

Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Dec 3;279(49):51630-46. Epub 2004 Sep 7.

Supplemental Content

Support Center